Orchestra BioMed Holdings, Inc. Quarterly General and Administrative Expense in USD from Q2 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q2 2020 to Q4 2022.
  • Orchestra BioMed Holdings, Inc. General and Administrative Expense for the quarter ending December 31, 2022 was $847K, a 1265% increase year-over-year.
  • Orchestra BioMed Holdings, Inc. General and Administrative Expense for the twelve months ending December 31, 2022 was $2.96M, a 977% increase year-over-year.
  • Orchestra BioMed Holdings, Inc. annual General and Administrative Expense for 2022 was $2.96M, a 977% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $847K +$785K +1265% Dec 31, 2022 10-K 2023-01-25
Q3 2022 $783K +$719K +1116% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $908K +$842K +1269% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $422K +$340K +415% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $62K Dec 31, 2021 10-K 2023-01-25
Q3 2021 $64.4K -$4.18K -6.09% Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $66.3K +$51.1K +336% Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $81.9K Mar 31, 2021 10-Q 2022-05-13
Q3 2020 $68.6K Sep 30, 2020 10-Q/A 2022-03-31
Q2 2020 $15.2K Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.